State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT04606095 N/A
Recruiting
Explosive Synchronization of Brain Network Activity in Chronic Pain
Condition
Fibromyalgia
Enrollment
150 pts
Location
United States
Sponsor
University of Michigan
NCT05958082 N/A
Recruiting
Utilization of Educational Interventions in Completion of Genetic Testing in Bla...
Condition
Prostate Cancer
Enrollment
50 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05988931 N/A
Recruiting
Technology Interventions for Youth Alcohol Use
Condition
Alcohol Drinking
Enrollment
1,400 pts
Location
United States
Sponsor
University of Michigan
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT07214961 Phase 1
Recruiting
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration ...
Condition
Prostate Cancer (CRPC)
Enrollment
80 pts
Location
United States
Sponsor
ARTBIO Inc.
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT06677151 N/A
Recruiting
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult O...
Condition
Sleep Apnea, Obstructive
Enrollment
20 pts
Location
United States
Sponsor
University of Michigan
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT03193151 N/A
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Condition
Liver Dysfunction
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06066502 Phase 3
Recruiting
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Condition
Breast Neoplasms
Enrollment
421 pts
Location
United States, Canada, France
Sponsor
Eli Lilly and Company
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.